Analyst
Credit Suisse
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
Judah Frommer is recorded as Analyst at Credit Suisse and Analyst at Morgan Stanley. Judah Frommer has spoken on 17 earnings calls and 17 other investor events across 17 companies, most recently for Zenas BioPharma, Inc. on September 29, 2026. Those appearances were for REGENXBIO Inc. (RGNX), Trevi Therapeutics, Inc. (TRVI), Ptc Therapeutics, Inc. (PTCT), COMPASS Pathways plc (CMPS), Zenas BioPharma, Inc. (ZBIO) and 12 other companies. The companies whose calls Judah Frommer spoke on are classified in the Healthcare sector.
“Maybe for Dr. Kess, just curious on your take for the convenience argument here. You know, do you have a sense for, you know, whether patients would prefer that weekly at-home kind of self-administration?”
“We're very excited to have the team from our cutest joining us. Let me just get through a quick disclosure before we get started. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com forward slash research disclosures.”
“We're very excited to have Tao Fu, President and CEO from Atovia, with us. Let me just get through a quick disclosure, Tao, before we get started. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morgansanley.com forward slash research disclosures.”
“We're very excited to kick off with the Regenexx team. We have Karen, Mitch, and Steve with us. Just before we get started, I'm going to read a quick disclosure.”
“We're very excited to kick off with the Regenexx team. We have Karen, Mitch, and Steve with us. Just before we get started, I'm going to read a quick disclosure.”
Credit Suisse
Analyst
Source not stated
Morgan Stanley
Analyst
Source not stated
RGNX
Biotechnology · Healthcare
CMPS
Medical Care Facilities · Healthcare
GMAB
Biotechnology · Healthcare
INCY
Biotechnology · Healthcare
BLTE
Biotechnology · Healthcare
Lakefront Biotherapeutics NV
Biotechnology · Healthcare
AVLN
Biotechnology · Healthcare
EVMN
Biotechnology · Healthcare
Morgan Stanley 24th Annual Global Healthcare Conference
Lakefront Biotherapeutics NV
